المؤلفون: Kanbay M; Division of Nephrology, Department of Medicine, Koc University School of Medicine, 34010, Istanbul, Turkey. drkanbay@yahoo.com., Bulbul MC; Department of Medicine, Koc University School of Medicine, Istanbul, Turkey., Copur S; Department of Medicine, Koc University School of Medicine, Istanbul, Turkey., Afsar B; Department of Internal Medicine, Division of Nephrology, Suleyman Demirel University School of Medicine, Isparta, Turkey., Sag AA; Division of Vascular and Interventional Radiology, Department of Radiology, Duke University Medical Center, Durham, USA., Siriopol D; Nephrology Clinic, Dialysis and Renal Transplant Center, 'C.I. PARHON' University Hospital, and 'Grigore T. Popa' University of Medicine, Iasi, Romania., Kuwabara M; Department of Cardiology, Toranomon Hospital, Tokyo, Japan., Badarau S; Nephrology Clinic, Dialysis and Renal Transplant Center, 'C.I. PARHON' University Hospital, and 'Grigore T. Popa' University of Medicine, Iasi, Romania., Covic A; Nephrology Clinic, Dialysis and Renal Transplant Center, 'C.I. PARHON' University Hospital, and 'Grigore T. Popa' University of Medicine, Iasi, Romania., Ortiz A; Dialysis Unit, School of Medicine, IIS-Fundacion Jimenez Diaz, Universidad Autónoma de Madrid, Avd. Reyes Católicos 2, 28040, Madrid, Spain.

المصدر: Journal of nephrology [J Nephrol] 2021 Jun; Vol. 34 (3), pp. 649-659. Date of Electronic Publication: 2020 May 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: Italy NLM ID: 9012268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6059 (Electronic) Linking ISSN: 11218428 NLM ISO Abbreviation: J Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Insulin Resistance* , Non-alcoholic Fatty Liver Disease*/diagnosis , Non-alcoholic Fatty Liver Disease*/drug therapy , Non-alcoholic Fatty Liver Disease*/epidemiology , Renal Insufficiency, Chronic*/diagnosis , Renal Insufficiency, Chronic*/epidemiology , Renal Insufficiency, Chronic*/therapy , Sodium-Glucose Transporter 2 Inhibitors*, China ; Humans